Healthcare - Biotechnology - NASDAQ - US
$ 26.27
-6.38 %
$ 3.27 B
Market Cap
-13.0
P/E
Price Target
Average
165.83%
Revenue Forecast
Estimate
38.72%
EBIT
Estimate
--14.25%
Net Income
Estimate
26.99%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets
Apellis Pharmaceuticals, Inc.
Wall Street analysts predict an average 1-year price target for APLS of $69.8 , with forecasts ranging from a low of $39 to a high of $96 .
APLS Lowest Price Target
Wall Street Target
39 USD
48.46%
APLS Average Price Target
Wall Street Target
69.8 USD
165.83%
APLS Highest Price Target
Wall Street Target
96 USD
265.44%
REVENUE FORECAST
Revenue Forecast Chart APLS
EBIT FORECAST
EBIT Forecast Chart APLS
NET INCOME FORECAST
Net Income Chart APLS